Iron starvation induces apoptosis in rhizopus oryzae in vitro

Références

• Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE Jr, Spellberg BJ. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 2007; 117:2649-657; PMID:17786247; http://dx.doi.org/10.1172/JCI32338
   PubMed Web of Science ®Google Scholar
• Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18:556-69; PMID:16020690; http://dx.doi.org/10.1128/CMR.18.3.556-569.2005
   PubMed Web of Science ®Google Scholar
• Ibrahim A, Gebremariam T, Lin L. The high affinity iron permease is a key virulence factor required for rhizopus oryzae pathogenesis. Mol Microbiol 2010; 77:587-604; PMID:20545847; http://dx.doi.org/10.1111/j.1365-2958.2010.07234.x
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30:851-56; PMID:10852735; http://dx.doi.org/10.1086/313803
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, Edwards JE Jr, Filler SG. Zygomycosis. in clinical mycology. Dismukes, W.E., Pappas, P.G., and Sobel, J.D. (eds). New York, NY:Oxford University Press, 2003; 241-51.
   Google Scholar
• Chamilos G, Lewis RE, Hu Jianhua, Xiao Lianchun, Zal T, Gillet M, Halder G, Kontoyiannis DP. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci USA 2008; 105:9367-372; PMID:18583479; http://dx.doi.org/10.1073/pnas.0709578105
   PubMed Web of Science ®Google Scholar
• Fu Y, Lee H, Collins M, Tsai HF, Spellberg B, Edwards JE Jr, Kwon-Chung KJ, Ibrahim AS. Cloning and functional characterization of the rhizopus oryzae high affinity iron permease (rFTR1) gene. FEMS Microbiol Lett 2004; 235:169-76; PMID:15158278; http://dx.doi.org/10.1111/j.1574-6968.2004.tb09583.x
   PubMed Web of Science ®Google Scholar
• Almeida B, Silva A, Mesquita A, Sampaio-Marques B, Rodrigues F, Ludovico P. Drug-induced apoptosis in yeast. Biochim Biophysica Acta Mol Cell Res 2008; 1783:1436-448; PMID:18252203; http://dx.doi.org/10.1016/j.bbamcr.2008.01.005
   PubMed Web of Science ®Google Scholar
• Ramsdale M. Programmed cell death in pathogenic fungi. Biochim Biophys Acta 2008; 1783:1369-380; PMID:18294459; http://dx.doi:10.1016/j.bbamcr.2008.01.021
   PubMed Web of Science ®Google Scholar
• Shirazi F, Kontoyiannis DP. Mitochondrial respiratory pathways inhibition in rhizopus oryzae potentiates activity of posaconazole and itraconazole via apoptosis. PLoS One 2013; 8:e63393; PMID:23696824; http://dx.doi.org/10.1371/journal.pone.0063393
   PubMed Web of Science ®Google Scholar
• Shirazi F, Kontoyiannis DP. The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against mucorales via apoptosis. Eukaryot Cell 2013; 12: 1225-234; PMID:23851337; http://dx.doi.org/10.1128/EC.00138-12
   PubMed Web of Science ®Google Scholar
• Maclean K, Yang H, Cleveland JL. Serum suppresses myeloid progenitor apoptosis by regulating iron homeostasis. J Cell Biochem 2001; 82:171-86; PMID:11400174; http://dx.doi.org/10.1002/jcb.1111
   PubMed Web of Science ®Google Scholar
• Simbula G, Glascott PA, Akita S, Hoek JB, Farber JL. Two mechanisms by which ATP depletion potentiates induction of the mitochondrial permeability transition. Am J Physiol 1997; 273:C479-88; PMID:9277345
   PubMedGoogle Scholar
• Kovar J, Stunz LL, Stewart BC, Kriegerbeckova K, Ashman RF, Kemp JD. Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. Pathobiol 1997; 65:61-8; PMID:9253029; http://dx.doi.org/10.1159/000164105
   PubMed Web of Science ®Google Scholar
• Hamann A, Brust D, Osiewacz HD. Apoptosis pathways in fungal growth, development and ageing. Trend Microbiol 2008; 16:276-83; PMID:18440231; http://dx.doi.org/10.1016/j.tim.2008.03.003
   PubMed Web of Science ®Google Scholar
• Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. The deferasirox-amBisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012; 67:715-22; PMID:21937481; http://dx.doi.org/10.1093/jac/dkr375
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Lahav M. Deferasirox as adjunctive therapy for mucormycosis. J Antimicrob Chemother. 2012; 67:519-20; PMID:22186877; http://dox.doi:org/10.1093/jac/dkr540
   PubMed Web of Science ®Google Scholar
• Spellberg B, Andes D, Perez M, Anglim A, Bonilla H, Mathisen GE, Walsh TJ, Ibrahim AS. Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis. Antimicrob Agents Chemother 2009; 53:3122-5; PMID:19433555; http://dox. doi:org/10.1128/AAC.00361-09
   PubMed Web of Science ®Google Scholar
• Lewis RE, Pongas GN, Albert N, Ben-Ami R, Walsh T, Kontoyiannis DP. Activity of deferasirox in mucorales: influences of species and exogenous iron. Antimirob Agents Chemother 2011; 55:411-13; PMID:20956598; http://dox. doi:10.1128/AAC.00792-10
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP. Antifungal activity of colistin against mucorales species in vitro and in a murine model of rhizopus oryzae pulmonary infection. Antimicrob Agent Chemother 2010; 54:484-90; PMID:19858263; http://dx.doi.org/10.1128/AAC.00956-09
   PubMed Web of Science ®Google Scholar